ACH
Price
$3.11
Change
-$0.09 (-2.81%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
245.07M
38 days until earnings call
Intraday BUY SELL Signals
FOCL
Price
$4.96
Change
+$0.06 (+1.22%)
Updated
Jun 23, 03:57 PM (EDT)
Capitalization
183.47M
64 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ACH vs FOCL

ACH vs FOCL Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ACH vs. FOCL commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ACH is a Hold and FOCL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ACH: $3.20 vs. FOCL: $4.89)
Brand notoriety: ACH and FOCL are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: ACH: 71% vs. FOCL: 101%
Market capitalization -- ACH: $245.07M vs. FOCL: $183.47M
ACH [@Medical Distributors] is valued at $245.07M. FOCL’s [@Medical Distributors] market capitalization is $183.47M. The market cap for tickers in the [@Medical Distributors] industry ranges from $89.44B to $0. The average market capitalization across the [@Medical Distributors] industry is $16.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ACH’s FA Score shows that 1 FA rating(s) are green whileFOCL’s FA Score has 0 green FA rating(s).

  • ACH’s FA Score: 1 green, 4 red.
  • FOCL’s FA Score: 0 green, 5 red.
According to our system of comparison, ACH is a better buy in the long-term than FOCL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ACH’s TA Score shows that 4 TA indicator(s) are bullish while FOCL’s TA Score has 4 bullish TA indicator(s).

  • ACH’s TA Score: 4 bullish, 5 bearish.
  • FOCL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, FOCL is a better buy in the short-term than ACH.

Price Growth

ACH (@Medical Distributors) experienced а +5.61% price change this week, while FOCL (@Medical Distributors) price change was +3.05% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was -1.15%. For the same industry, the average monthly price growth was -4.05%, and the average quarterly price growth was -7.30%.

Reported Earning Dates

ACH is expected to report earnings on Jul 31, 2026.

FOCL is expected to report earnings on Aug 26, 2026.

Industries' Descriptions

@Medical Distributors (-1.15% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ACH($245M) has a higher market cap than FOCL($183M). FOCL YTD gains are higher at: 48.784 vs. ACH (14.286). ACH has higher annual earnings (EBITDA): 236M vs. FOCL (-25.53M). ACH has more cash in the bank: 337M vs. FOCL (15M). FOCL has less debt than ACH: FOCL (27.8M) vs ACH (2.17B). ACH has higher revenues than FOCL: ACH (2.72B) vs FOCL (74.1M).
ACHFOCLACH / FOCL
Capitalization245M183M134%
EBITDA236M-25.53M-925%
Gain YTD14.28648.78429%
P/E RatioN/AN/A-
Revenue2.72B74.1M3,665%
Total Cash337M15M2,247%
Total Debt2.17B27.8M7,809%
FUNDAMENTALS RATINGS
ACH vs FOCL: Fundamental Ratings
ACH
FOCL
OUTLOOK RATING
1..100
3318
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10099
PRICE GROWTH RATING
1..100
4337
P/E GROWTH RATING
1..100
9999
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ACH's Valuation (19) in the Aluminum industry is significantly better than the same rating for FOCL (98) in the Biotechnology industry. This means that ACH’s stock grew significantly faster than FOCL’s over the last 12 months.

ACH's Profit vs Risk Rating (100) in the Aluminum industry is in the same range as FOCL (100) in the Biotechnology industry. This means that ACH’s stock grew similarly to FOCL’s over the last 12 months.

FOCL's SMR Rating (99) in the Biotechnology industry is in the same range as ACH (100) in the Aluminum industry. This means that FOCL’s stock grew similarly to ACH’s over the last 12 months.

FOCL's Price Growth Rating (37) in the Biotechnology industry is in the same range as ACH (43) in the Aluminum industry. This means that FOCL’s stock grew similarly to ACH’s over the last 12 months.

FOCL's P/E Growth Rating (99) in the Biotechnology industry is in the same range as ACH (99) in the Aluminum industry. This means that FOCL’s stock grew similarly to ACH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ACHFOCL
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
84%
Momentum
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
71%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 6 days ago
74%
Bullish Trend 8 days ago
73%
Declines
ODDS (%)
Bearish Trend 23 days ago
86%
Bearish Trend 21 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ACH
Daily Signal:
Gain/Loss:
FOCL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CIHEX20.25N/A
N/A
Calamos Hedged Equity I
RMYSX10.58N/A
N/A
Russell Inv Multi-Strategy Income S
PGKCX33.58N/A
N/A
PGIM Jennison Technology C
FECMX63.60N/A
N/A
Fidelity Advisor Emerging Markets I
CRLSX12.86N/A
N/A
Catholic Rspnsbl Invstmnts Intl Eq Ins

FOCL and

Correlation & Price change

A.I.dvisor tells us that FOCL and AORT have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FOCL and AORT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FOCL
1D Price
Change %
FOCL100%
+1.77%
AORT - FOCL
29%
Poorly correlated
-5.00%
AVNS - FOCL
21%
Poorly correlated
-0.16%
UFPT - FOCL
20%
Poorly correlated
-2.50%
SENS - FOCL
20%
Poorly correlated
-5.64%
STXS - FOCL
16%
Poorly correlated
-0.53%
More